(Credit: Chizhevskaya Ekaterina/Shutterstock)
This Gut Chemical Didn’t Stop Epilepsy in Mice, But It Made It Far Milder
In A Nutshell
- Mice given injections of sodium butyrate after a severe brain injury saw total seizure time drop by about 86%, and averaged roughly 70% fewer seizures overall than untreated mice.
- The compound didn’t prevent epilepsy from developing (most mice in both groups eventually had seizures), but it made the disease dramatically milder once it showed up.
- Treated mice also had calmer, less inflamed brains, held onto more neurons, and recovered better physically, though their memory problems didn’t improve.
- The mice received high-dose injections, not dietary fiber or supplements, so this is not something people can replicate at home; the findings are early and haven’t been tested in humans.
Every year, roughly 70 million people around the world suffer a traumatic brain injury. For many, the ordeal doesn’t end when they leave the hospital. Weeks, months, or years later, an injured brain can start experiencing seizures seemingly out of nowhere, a condition doctors call post-traumatic epilepsy. Unfortunately, medicine currently has no proven way to address it before it starts.
A new study out of Texas A&M, published in Experimental Neurology, offers a genuinely hopeful lead. Researchers gave mice a compound called sodium butyrate, related to something the gut’s own bacteria naturally make, right after a severe brain injury. Across the treated group, total time spent seizing fell by about 86%, from roughly seven and a half hours down to just over one. A mouse that would have had a seizure every other day instead had one about once a week. Treated animals also had calmer brains, held onto more neurons, and moved and learned better than untreated ones.
Nobody ate their way into this result. These mice got high-dose shots twice a day for three weeks, starting an hour after injury, at levels no diet or supplement could match. This isn’t an “add more yogurt” story, and anyone who’s had a seizure or head injury should see a doctor, not their pantry.
Brain Injuries Trigger a Slow Chemical Cascade That Ends in Seizures
The unpredictable part about a bad head injury is that the impact itself isn’t always the worst of it. In the weeks after, the brain kicks into overdrive, inflammation surges, and cells meant to protect it start overreacting and doing damage of their own, slowly rewiring itself into something more prone to misfiring, a process called epileptogenesis, less a single bad moment than a fuse that keeps burning.
One driver seems to be a group of enzymes called HDACs, which act like switches controlling which genes get read. After injury, these switches get stuck running hot, and researchers think that’s part of what keeps the damage going. Sodium butyrate appears to calm them back toward normal, which may be why treated mice fared better.
Injected Mice Got High Doses for Three Weeks After Injury
Adult male mice got a deliberately severe injury to a memory-related brain region called the hippocampus, the kind designed to reliably trigger epilepsy down the road. Starting an hour after surgery, one group got sodium butyrate shots (600 milligrams per kilogram, a hefty clinical dose) twice daily for three weeks; a second injured group got saline; a third had surgery but skipped the injury, serving as a healthy baseline. Researchers watched the mice around the clock for four months using brain wave monitors, with every seizure double-checked on video by reviewers unaware of group assignment. Groups were small (10 healthy, 18 untreated injured, 11 treated injured), and more untreated mice died than treated ones over that time (28% versus 10%), though the study wasn’t big enough to say the treatment itself saved lives.
Seizures Dropped Sharply, but Epilepsy Still Developed in Most Mice
Here’s the honest part: sodium butyrate didn’t stop epilepsy from showing up. Eighty-five percent of untreated mice and 75% of treated mice eventually had seizures on their own, and both groups took about the same time to have their first one. What it did do was shrink the disease once it arrived. Treated mice had far fewer seizures, each one was shorter, and they needed a stronger jolt to trigger a seizure by the end of the study, a sign the underlying condition may have been getting milder, not just quieter. Inflammation followed the same pattern: within the first week, treated mice already had calmer brain tissue than untreated ones, and four months later that gap hadn’t closed. Treated mice also held onto more brain cells on the side opposite the injury (the only side researchers could reliably examine, since the injury site itself was too damaged to measure) and grew more new neurons.
Behaviorally, things were encouraging but mixed. Treated mice put weight back on faster, moved with better coordination, and seemed less anxious, but on remembering what they’d learned in a water maze, treated mice were no better off than untreated ones; treatment sped up learning without fixing the memory problem.
A Reason to Keep Testing, Not a Treatment Yet
Researchers point to something they call the “latent period,” the stretch between injury and when seizures show up, when damage is quietly building even though nothing looks wrong yet. Catching the brain in that in-between stage may be the best shot at changing where things end up. A related drug, valproic acid, which also works on those same HDAC switches, already reached human trials and failed to stop this same kind of epilepsy, a reminder that a good result in mice guarantees nothing once people are involved.
Moreover, every mouse was male and adult, the equipment couldn’t pinpoint exactly where seizures started, and sodium butyrate affects a wide swath of enzymes rather than one precise target, so researchers can’t say which effect matters most. This study offers a solid reason to keep testing, not a treatment anyone can use yet. Next steps likely include testing female and older mice, starting treatment later since real patients rarely get help within the hour, and determining whether these doses could ever be given to a person safely.
Disclaimer: This article is for general informational purposes only and does not constitute medical advice. The study described involved injected sodium butyrate in mice under controlled laboratory conditions; it does not show that dietary changes, fiber intake, or over-the-counter supplements have any effect on seizures or brain injury recovery in humans. Anyone who has experienced a head injury or a seizure should seek immediate medical attention rather than act on this research.
Paper Notes
Limitations
The authors acknowledge several important constraints in interpreting these findings. The study used only adult male mice, which limits conclusions about sex- and age-related differences in response to treatment. Brain wave recording was conducted with two electrodes rather than a multi-site system, meaning the precise location where seizures originated could not be definitively identified. Because the injury was severe enough to destroy much of the hippocampus on the injured side of the brain, neuropathological analysis was conducted primarily on the opposite side, limiting direct evaluation of tissue protection at the primary injury site. The study was also not statistically powered to detect differences in the overall proportion of animals that developed epilepsy, only in seizure burden and related measures. Finally, because sodium butyrate inhibits a broad class of enzymes rather than a single specific target, the study cannot resolve which cells or molecular pathways are most responsible for the observed effects. The authors call for future studies using more selective inhibitors, multi-site recording, and both sexes and ages.
Funding and Disclosures
According to the paper, this work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Epilepsy Research Program, the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, and a Texas A&M Presidential X-Grant award. The authors note that opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Department of Defense, the National Institutes of Health, or Texas A&M University. The paper states that the co-authors declare no competing interests.
Publication Details
Authors: Victoria M. Golub, Sreevidhya Ramakrishnan, and Doodipala Samba Reddy Affiliation: Department of Neuroscience and Experimental Therapeutics, Vashisht College of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA Journal: Experimental Neurology, Volume 404 (2026), Article 115857 Paper Title: “Epigenetic histone deacetylase inhibition by sodium butyrate reduces neuroinflammation, improves neurological dysfunction and promotes disease modification of epileptogenesis following traumatic brain injury” DOI: https://doi.org/10.1016/j.expneurol.2026.115857 Published online: May 28, 2026 Note: This article is part of a special issue titled “Converging Approaches for Post-traumatic Epilepsy” published in Experimental Neurology.
